What is Pylarify, and what is it used for?
Pylarify is the brand name for a radiopharmaceutical called piflufolastat F 18. It is used for positron emission tomography (PET) imaging to help doctors detect prostate cancer that is likely to have spread, such as in patients who are being evaluated because prostate-specific antigen (PSA) levels are rising after treatment or who have other clinical reasons to suspect recurrence or metastasis. [1]
How does Pylarify PET imaging work?
Pylarify contains a radioactive tracer (piflufolastat labeled with fluorine-18, F 18). After injection, the tracer helps visualize prostate cancer tissue on a PET scan, giving clinicians information about where cancer is present in the body. [1]
What does a Pylarify scan help doctors decide?
Results from Pylarify PET imaging can support clinical decision-making for prostate cancer management by showing suspected sites of disease (for example, when PSA rises after therapy). This can help guide next steps such as further treatment planning and assessment of the extent of disease. [1]
Who is Pylarify for?
Pylarify is intended for patients with prostate cancer in clinical settings where PET imaging is used to evaluate for suspected spread or recurrence, including cases driven by rising PSA after prior treatment. [1]
Is Pylarify the same as other prostate cancer PET tracers?
Pylarify is one specific prostate cancer PET tracer (piflufolastat F 18). It is distinct from other prostate cancer imaging products that use different tracers and targets, even though all are used for PET imaging to help detect prostate cancer distribution. [1]
Sources
- https://www.pylarify.com/